For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Sign up for latest coverage
Submit your event
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Prevention & screening
Middle East and North Africa
Central America and the Caribbean
Australia and Oceania
5 - 9 Apr 2014
TBA, San Diego, CA, United States of America
Mayo Clinic launches 50-gene cancer panel test
AACR: Targeted investigational therapy shows early promise against multiple cancer types
AACR: New immunotherapy IMCgp100 shows Early promise in advanced melanoma patients
AACR: Study identifies frequent cause of breast cancer resistance to investigational PI3K-alpha inhi...
AACR: Investigational anticancer drug may benefit subgroup of patients with head and neck cancer
AACR: Blood-based biomarker may identify prostate cancers that will be resistant to enzalutamide
AACR: Study identifies potential approach to overcome breast cancer resistance to HER2-targeted ther...
AACR: Irregular menstruation may predict Increased risk of death from ovarian cancer
AACR: Higher coffee intake may reduce liver cancer risk
AACR: Prediagnosis obesity predicts poor outcome for colorectal cancer patients, even those with a t...
AACR: I-SPY 2 Trial identifies subset of breast cancer patients most likely to benefit from neratini...
AACR: New antibody-drug conjugate shows early promise against all forms of melanoma
AACR: Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475
AACR: First-in-class cancer metabolism drug AG-221 shows clinical activity in advanced blood cancers
AACR: New drug demonstrates early promise in metastatic breast cancer
AACR: Study identifies potential predictor of clinical outcome in patients with lung cancer treated ...